Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
NEWARK, Calif., March 10, 2025 (Ecnetnews.com) - Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced positive topline results from ...